SLE - hematopoietic stem cell transplantation for systemic lupus erythematosus.
Hematopoietic stem cell transplantation was first reported for patients with systemic lupus erythematosus in 1997. The procedure has since been performed worldwide including in Europe, in Brazil, and in China. A National Institutes of Health-funded phase III clinical trial of hematopoietic stem cell transplantation for refractory systemic lupus erythematosus is anticipated to begin in 2003. Encouraging responses are raising new hope about the role of adult hematopoietic stem cells in systemic lupus erythematosus.
Burt
Richard K
RK
Division of Immunotherapy, Northwestern University School of Medicine, Chicago, Illinois, USA. rburt@nwu.edu
Traynor
Ann E
AE
D018380:Hematopoietic Stem Cell Transplantation / Q000379:methods*; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000628:therapy*